Globally, fertility clinics generated revenue of approximately $9 billion in 2017. The United States accounted for $3.6 billion of this market in the same year and the industry is expected to grow by almost a billion dollars by 2022.
Consolidation in the fertility space has been occurring at a rapid pace for the past several years. Driven primarily by private equity investment to create platforms for subsequent add-on investments, transaction volume since 2015 has been expansive and driven by both established players and new entrants to the sector.
With a dramatic increase in the number of women and couples seeking medical and scientific assistance to start or grow a family in recent years, industry growth is strong. In addition to demographic trends, growth in the Fertility Industry in the US has been driven by the increased inclusion of fertility services in private health insurance plans.
In our Fertility Industry Report, we explore a sector overview, demand trends, industry transaction activity, insights into select active acquirers, and more.
To read the full Fertility Industry Report, download below.
Objective Capital Partners has decades of experience and our tenacious advocacy for our clients has allowed us to create and maintain relationships with active acquirers and investors in our industries of focus. Whether preparing for sale or strategizing for future exit options, knowing the active acquirers and investors within your industry niche is an important factor in achieving your transaction goals.
If you are interested in learning more about the trends and insights in the Fertility Industry, or if you would like to discuss your own acquisition goals, contact us at (800) 849-7010 or [email protected].
About the Author:
Ravin Bisla
Director, Life Sciences & Healthcare
15+ Years of Experience
—
Disclosure
Objective Capital Partners is a leading investment banking advisory firm whose Principals have collectively engaged in more than 500 successful transactions serving the transaction needs of growth stage and mid-size companies. The executive team has a unique combination of investment banking, private equity, and business ownership experience that enables Objective Capital Partners to provide large enterprise caliber investment banking services to companies with annual revenues up to $250MM. Services include sale transactions, partnering/ licensing, equity and debt capital raises, valuation and comprehensive advisory services. The firm uses a proprietary process to work to achieve maximum company valuation, premium pricing, and high client satisfaction rates post-sale. The firm’s industry expertise is focused on 5 verticals including healthcare, life sciences, business services, technology, and consumer products. Additional information on Objective Capital Partners is available at www.objectiveibv.com.
This article is for informational purposes only and does not constitute an offer, invitation or recommendation to buy, sell, subscribe for or issue any securities. While the information provided herein is believed to be accurate and reliable, Objective Capital Partners and BA Securities, LLC make no representations or warranties, expressed or implied, as to the accuracy or completeness of such information. All information contained herein is preliminary, limited and subject to completion, correction or amendment. It should not be construed as investment, legal, or tax advice and may not be reproduced or distributed to any person. Securities and investment banking services are offered through BA Securities, LLC Member FINRA, SIPC. Principals of Objective Capital are Registered Representatives of BA Securities. Objective Capital Partners and BA Securities are separate and unaffiliated entities.
